REPORTS

Let’s Pullulate and Expand Your Business

Biopharmaceuticals Market - Global Professional Analysis and Forecast to 2026

Oct 21, 2019  |  206 PAGES  |  REPORT CODE: CMM219781
  • REPORT SUMMARY
  • TABLE OF CONTENTS
  • INDUSTRY COVERAGE

The worldwide Biopharmaceuticals market was valued at 176480 Million US$ in 2018 and is projected to reach 359465 Million US$ by 2026, at a CAGR (Compound Annual Growth Rate) of 9.3% during the forecast period.

This report presents the market size and development trends by detailing the Biopharmaceuticals market revenue, market share and growth rate from 2015-2026, and it gives a thorough analysis by various product types, applications, regions, and main participants. The market conditions (2015-2019), corporate competition pattern, corporate SWOT analysis are elaborated, and other qualitative analyses like market dynamics, market penetration, market business environment analyses, the regional regulatory scenario in the Biopharmaceuticals market will be shown in this report. In short, this report will comprehensively reveal the characteristics of Biopharmaceuticals industry and will help you to build a panoramic view of the industrial development.

Biopharmaceuticals Market, By Type:

  • Monoclonal Antibodies

  • Interferon

  • Colony-Stimulating Factor

  • Erythropoietin

  • Insulin

  • Vaccines

  • Growth Hormones

  • Others

Biopharmaceuticals Market, By Application:

  • Tumor

  • Diabetes

  • Cardiovascular

  • Hemophilia

  • Others

Some of the leading players are as follows:

  • Amgen

  • Novo Nordisk

  • Novartis

  • Eli Lilly

  • Sanofi-Aventis

  • Merck

  • Roche

  • AbbVie

  • Johnson & Johnson

  • Pfizer

Geographically, Major regions are analyzed in details are as follows:

  • North America

  • Europe

  • Asia Pacific

  • Latin America

  • Middle East & Africa

Table of Contents

1 Methodology and Scope

  • 1.1 Market Segmentation & Scope

    • 1.1.1 Technology Type

    • 1.1.2 Product

    • 1.1.3 Application

    • 1.1.4 Regional scope

    • 1.1.5 Estimates and forecast timeline

  • 1.2 Research Methodology

  • 1.3 Information Procurement

    • 1.3.1 Purchased database

    • 1.3.2 Internal database

    • 1.3.3 Secondary sources

    • 1.3.4 Primary research

    • 1.3.5 Details of primary research

  • 1.4 Information or Data Analysis

    • 1.4.1 Data analysis models

  • 1.5 Market Formulation & Validation

  • 1.6 Model Details

    • 1.6.1 Commodity flow analysis

    • 1.6.2 Volume price analysis

  • 1.7 List of Secondary Sources

  • 1.8 List of Abbreviations

2 Executive Summary

  • 2.1 Market Outlook

  • 2.2 Segment Outlook

3 Market Variables, Trends, & Scope

  • 3.1 Market Lineage Outlook

  • 3.1.1 Parent market outlook

    • 3.1.2 Ancillary market outlook

  • 3.2 Market Segmentation

    • 3.2.1 Analysis

  • 3.3 Market Dynamics

    • 3.3.1 Market driver analysis

    • 3.3.2 Market restraint analysis

    • 3.3.3 Industry opportunities

  • 3.4 Penetration & Growth Prospect Mapping

    • 3.4.1 Penetration & growth prospect mapping analysis

  • 3.5 Business Environment Analysis Tools

    • 3.5.1 Porter's five forces analysis

    • 3.5.2 PESTLE analysis

    • 3.5.3 Major deals & strategic alliances analysis

4 Biopharmaceuticals Market: Technology Type Analysis

  • 4.1 Biopharmaceuticals Technology Type Market Share Analysis, 2018 & 2026

  • 4.2 Biopharmaceuticals Technology Type Market: Segment Dashboard

  • 4.3 Market Size & Forecasts and Trend Analyses, 2015 to 2026 for the Technology Type Segment

    • 4.3.1 Monoclonal Antibodies

    • 4.3.2 Interferon

    • 4.3.3 Colony-Stimulating Factor

    • 4.3.4 Erythropoietin

    • 4.3.5 Insulin

    • 4.3.6 Vaccines

    • 4.3.7 Growth Hormones

    • 4.3.8 Others

5 Biopharmaceuticals Market: Product Analysis

  • 5.1 Biopharmaceuticals Product Market Share Analysis, 2018 & 2026

  • 5.2 Biopharmaceuticals Product Market: Segment Dashboard

  • 5.3 Market Size & Forecasts and Trend Analyses, 2015 to 2026 for the Product Segment

6 Biopharmaceuticals Market: Application Analysis

  • 6.1 Biopharmaceuticals Application Market Share Analysis, 2018 & 2026

  • 6.2 Biopharmaceuticals Application Market: Segment Dashboard

  • 6.3 Market Size & Forecasts and Trend Analyses, 2015 to 2026 for the Application Segment

    • 6.3.1 Tumor

    • 6.3.2 Diabetes

    • 6.3.3 Cardiovascular

    • 6.3.4 Hemophilia

    • 6.3.5 Others

7 Biopharmaceuticals Market: Regional Analysis

  • 7.1 Biopharmaceuticals Regional Market Share Analysis, 2018 & 2026

  • 7.2 Biopharmaceuticals Regional Market: Segment Dashboard

  • 7.3 Regional Market Snapshot (Market Size, CAGR, Top Countries)

  • 7.4 List of Players at Regional Level

    • 7.4.1 North America

    • 7.4.2 Europe

    • 7.4.3 Asia Pacific

  • 7.5 SWOT Analysis, by Factor (Political & Legal, Economic and Technological)

    • 7.5.1 North America

    • 7.5.2 Europe

    • 7.5.3 Asia Pacific

    • 7.5.4 Latin America

    • 7.5.5 MEA

  • 7.6 Market Size & Forecasts, and Trend Analysis, 2015 to 2026

    • 7.6.1 North America

    • 7.6.2 Europe

    • 7.6.3 Asia Pacific

    • 7.6.4 Latin America

    • 7.6.5 Middle East & Africa

8 Competitive Analysis

  • 8.1 Recent Developments & Impact Analysis, by Key Market Participants

  • 8.2 Strategic Framework/Competition Categorization (Key innovators, Market leaders, Emerging players)

  • 8.3 Vendor Landscape

    • 8.3.1 Company market position analysis (Geographic presence, service portfolio, strategic initiatives)

9 Company Profiles

  • 9.1 Amgen

    • 9.1.1 Amgen Company overview

    • 9.1.2 Financial performance

    • 9.1.3 Product benchmarking

    • 9.1.4 Strategic initiatives

    • 9.1.5 SWOT analysis

  • 9.2 Novo Nordisk

    • 9.2.1 Novo Nordisk Company overview

    • 9.2.2 Financial performance

    • 9.2.3 Product benchmarking

    • 9.2.4 Strategic initiatives

    • 9.2.5 SWOT analysis

  • 9.3 Novartis

    • 9.3.1 Novartis Company overview

    • 9.3.2 Financial performance

    • 9.3.3 Product benchmarking

    • 9.3.4 Strategic initiatives

    • 9.3.5 SWOT analysis

  • 9.4 Eli Lilly

    • 9.4.1 Eli Lilly Company overview

    • 9.4.2 Financial performance

    • 9.4.3 Product benchmarking

    • 9.4.4 Strategic initiatives

    • 9.4.5 SWOT analysis

  • 9.5 Sanofi-Aventis

    • 9.5.1 Sanofi-Aventis Company overview

    • 9.5.2 Financial performance

    • 9.5.3 Product benchmarking

    • 9.5.4 Strategic initiatives

    • 9.5.5 SWOT analysis

  • 9.6 Merck

    • 9.6.1 Merck Company overview

    • 9.6.2 Financial performance

    • 9.6.3 Product benchmarking

    • 9.6.4 Strategic initiatives

    • 9.6.5 SWOT analysis

  • 9.7 Roche

    • 9.7.1 Roche Company overview

    • 9.7.2 Financial performance

    • 9.7.3 Product benchmarking

    • 9.7.4 Strategic initiatives

    • 9.7.5 SWOT analysis

  • 9.8 AbbVie

    • 9.8.1 AbbVie Company overview

    • 9.8.2 Financial performance

    • 9.8.3 Product benchmarking

    • 9.8.4 Strategic initiatives

    • 9.8.5 SWOT analysis

  • 9.9 Johnson & Johnson

    • 9.9.1 Johnson & Johnson Company overview

    • 9.9.2 Financial performance

    • 9.9.3 Product benchmarking

    • 9.9.4 Strategic initiatives

    • 9.9.5 SWOT analysis

  • 9.10 Pfizer

    • 9.10.1 Pfizer Company overview

    • 9.10.2 Financial performance

    • 9.10.3 Product benchmarking

    • 9.10.4 Strategic initiatives

    • 9.10.5 SWOT analysis

 

The List of Tables and Figures (Totals 96 Figures and 135 Tables)

  • Figure Monoclonal Antibodies Biopharmaceuticals market, 2015 - 2026 (USD Million)

  • Figure Interferon Biopharmaceuticals market, 2015 - 2026 (USD Million)

  • Figure Colony-Stimulating Factor Biopharmaceuticals market, 2015 - 2026 (USD Million)

  • Figure Erythropoietin Biopharmaceuticals market, 2015 - 2026 (USD Million)

  • Figure Insulin Biopharmaceuticals market, 2015 - 2026 (USD Million)

  • Figure Vaccines Biopharmaceuticals market, 2015 - 2026 (USD Million)

  • Figure Growth Hormones Biopharmaceuticals market, 2015 - 2026 (USD Million)

  • Figure Others Biopharmaceuticals market, 2015 - 2026 (USD Million)

  • Figure Tumor market, 2015 - 2026 (USD Million)

  • Figure Diabetes market, 2015 - 2026 (USD Million)

  • Figure Cardiovascular market, 2015 - 2026 (USD Million)

  • Figure Hemophilia market, 2015 - 2026 (USD Million)

  • Figure Others market, 2015 - 2026 (USD Million)

  • Table List of players in North America

  • Table List of players in Europe

  • Table List of players in Asia Pacific

  • Table SWOT analysis

  • Table North America Biopharmaceuticals market, by country, 2015 - 2026 (USD Million)

  • Table North America Biopharmaceuticals market, by type, 2015 - 2026 (USD Million)

  • Table North America Biopharmaceuticals market, by product, 2015 - 2026 (USD Million)

  • Table North America Biopharmaceuticals market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table U.S. Biopharmaceuticals market, by type, 2015 - 2026 (USD Million)

  • Table U.S. Biopharmaceuticals market, by product, 2015 - 2026 (USD Million)

  • Table U.S. Biopharmaceuticals market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table Canada Biopharmaceuticals market, by type, 2015 - 2026 (USD Million)

  • Table Canada Biopharmaceuticals market, by product, 2015 - 2026 (USD Million)

  • Table Canada Biopharmaceuticals market, by application, 2015 - 2026 (USD Million)

  • Table Europe Biopharmaceuticals market, by country, 2015 - 2026 (USD Million)

  • Table Europe Biopharmaceuticals market, by type, 2015 - 2026 (USD Million)

  • Table Europe Biopharmaceuticals market, by product, 2015 - 2026 (USD Million)

  • Table Europe Biopharmaceuticals market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table U.K. Biopharmaceuticals market, by type, 2015 - 2026 (USD Million)

  • Table U.K. Biopharmaceuticals market, by product, 2015 - 2026 (USD Million)

  • Table U.K. Biopharmaceuticals market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table Germany Biopharmaceuticals market, by type, 2015 - 2026 (USD Million)

  • Table Germany Biopharmaceuticals market, by product, 2015 - 2026 (USD Million)

  • Table Germany Biopharmaceuticals market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table France Biopharmaceuticals market, by type, 2015 - 2026 (USD Million)

  • Table France Biopharmaceuticals market, by product, 2015 - 2026 (USD Million)

  • Table France Biopharmaceuticals market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table Italy Biopharmaceuticals market, by type, 2015 - 2026 (USD Million)

  • Table Italy Biopharmaceuticals market, by product, 2015 - 2026 (USD Million)

  • Table Italy Biopharmaceuticals market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table Spain Biopharmaceuticals market, by type, 2015 - 2026 (USD Million)

  • Table Spain Biopharmaceuticals market, by product, 2015 - 2026 (USD Million)

  • Table Spain Biopharmaceuticals market, by application, 2015 - 2026 (USD Million)

  • Table Asia Pacific Biopharmaceuticals market, by country, 2015 - 2026 (USD Million)

  • Table Asia Pacific Biopharmaceuticals market, by type, 2015 - 2026 (USD Million)

  • Table Asia Pacific Biopharmaceuticals market, by product, 2015 - 2026 (USD Million)

  • Table Asia Pacific Biopharmaceuticals market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table China Biopharmaceuticals market, by type, 2015 - 2026 (USD Million)

  • Table China Biopharmaceuticals market, by product, 2015 - 2026 (USD Million)

  • Table China Biopharmaceuticals market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table Japan Biopharmaceuticals market, by type, 2015 - 2026 (USD Million)

  • Table Japan Biopharmaceuticals market, by product, 2015 - 2026 (USD Million)

  • Table Japan Biopharmaceuticals market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table India Biopharmaceuticals market, by type, 2015 - 2026 (USD Million)

  • Table India Biopharmaceuticals market, by product, 2015 - 2026 (USD Million)

  • Table India Biopharmaceuticals market, by application, 2015 - 2026 (USD Million)

  • Table Latin America Biopharmaceuticals market, by country, 2015 - 2026 (USD Million)

  • Table Latin America Biopharmaceuticals market, by type, 2015 - 2026 (USD Million)

  • Table Latin America Biopharmaceuticals market, by product, 2015 - 2026 (USD Million)

  • Table Latin America Biopharmaceuticals market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table Brazil Biopharmaceuticals market, by type, 2015 - 2026 (USD Million)

  • Table Brazil Biopharmaceuticals market, by product, 2015 - 2026 (USD Million)

  • Table Brazil Biopharmaceuticals market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table Mexico Biopharmaceuticals market, by type, 2015 - 2026 (USD Million)

  • Table Mexico Biopharmaceuticals market, by product, 2015 - 2026 (USD Million)

  • Table Mexico Biopharmaceuticals market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table Argentina Biopharmaceuticals market, by type, 2015 - 2026 (USD Million)

  • Table Argentina Biopharmaceuticals market, by product, 2015 - 2026 (USD Million)

  • Table Argentina Biopharmaceuticals market, by application, 2015 - 2026 (USD Million)

  • Table MEA Biopharmaceuticals market, by country, 2015 - 2026 (USD Million)

  • Table MEA Biopharmaceuticals market, by type, 2015 - 2026 (USD Million)

  • Table MEA Biopharmaceuticals market, by product, 2015 - 2026 (USD Million)

  • Table MEA Biopharmaceuticals market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table South Africa Biopharmaceuticals market, by type, 2015 - 2026 (USD Million)

  • Table South Africa Biopharmaceuticals market, by product, 2015 - 2026 (USD Million)

  • Table South Africa Biopharmaceuticals market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table Nigeria Biopharmaceuticals market, by type, 2015 - 2026 (USD Million)

  • Table Nigeria Biopharmaceuticals market, by product, 2015 - 2026 (USD Million)

  • Table Nigeria Biopharmaceuticals market, by application, 2015 - 2026 (USD Million)

  • Table Recent Developments & Impact Analysis, by Key Market Participants

  • Table Recent Developments & Impact Analysis, by Key Market Participants

  • Table Company market position analysis

  • Table Company Profiles

  • Table Amgen Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table Novo Nordisk Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table Novartis Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table Eli Lilly Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table Sanofi-Aventis Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table Merck Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table Roche Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table AbbVie Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table Johnson & Johnson Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table Pfizer Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

Report Purchase

reports
$4840
$9680
BUY NOWClick MeBUY NOW
top